688247 宣泰医药
已收盘 11-18 15:00:00
资讯
新帖
简况
股市必读:宣泰医药(688247)11月17日董秘有最新回复
证券之星 · 11-18 03:26
股市必读:宣泰医药(688247)11月17日董秘有最新回复
宣泰医药:11月12日召开业绩说明会,投资者参与
证券之星 · 11-17 19:17
宣泰医药:11月12日召开业绩说明会,投资者参与
股市必读:宣泰医药新发布《自愿披露关于泊沙康唑肠溶片获得哥伦比亚INVIMA批准文号的公告》
证券之星 · 11-16 03:37
股市必读:宣泰医药新发布《自愿披露关于泊沙康唑肠溶片获得哥伦比亚INVIMA批准文号的公告》
宣泰医药(688247)11月12日主力资金净买入1533.01万元
证券之星 · 11-13
宣泰医药(688247)11月12日主力资金净买入1533.01万元
宣泰医药(688247.SH):泊沙康唑肠溶片获得哥伦比亚INVIMA批准文号
智通财经 · 11-12
宣泰医药(688247.SH):泊沙康唑肠溶片获得哥伦比亚INVIMA批准文号
股市必读:宣泰医药三季报 - 第三季度单季净利润同比下降75.51%
证券之星 · 10-30
股市必读:宣泰医药三季报 - 第三季度单季净利润同比下降75.51%
股市必读:宣泰医药(688247)股东户数1.05万户,较上期增加36.59%
证券之星 · 10-29
股市必读:宣泰医药(688247)股东户数1.05万户,较上期增加36.59%
宣泰医药(688247.SH)发布前三季度业绩,归母净利润3408万元,同比下降46.30%
智通财经 · 10-28
宣泰医药(688247.SH)发布前三季度业绩,归母净利润3408万元,同比下降46.30%
宣泰医药(688247)10月27日主力资金净卖出59.08万元
证券之星 · 10-28
宣泰医药(688247)10月27日主力资金净卖出59.08万元
股市必读:宣泰医药新发布《关于股东部分股份解除质押的公告-1015_final》
证券之星 · 10-21
股市必读:宣泰医药新发布《关于股东部分股份解除质押的公告-1015_final》
宣泰医药(688247)披露2026年半年度权益分派实施公告,10月19日股价下跌2.6%
证券之星 · 10-19
宣泰医药(688247)披露2026年半年度权益分派实施公告,10月19日股价下跌2.6%
股市必读:宣泰医药新发布《关于股东无偿捐赠部分公司股份完成过户的公告》
证券之星 · 10-19
股市必读:宣泰医药新发布《关于股东无偿捐赠部分公司股份完成过户的公告》
宣泰医药:Finer捐赠20万股完成过户
同花顺 · 10-15
宣泰医药:Finer捐赠20万股完成过户
宣泰医药(688247)10月8日主力资金净卖出498.32万元
证券之星 · 10-09
宣泰医药(688247)10月8日主力资金净卖出498.32万元
宣泰医药(688247)9月28日主力资金净卖出200.76万元
证券之星 · 09-29
宣泰医药(688247)9月28日主力资金净卖出200.76万元
宣泰医药(688247)9月23日主力资金净买入699.18万元
证券之星 · 09-24
宣泰医药(688247)9月23日主力资金净买入699.18万元
宣泰医药:9月15日召开业绩说明会,投资者参与
证券之星 · 09-16
宣泰医药:9月15日召开业绩说明会,投资者参与
宣泰医药新提交“宣佳泰”、“宣家泰”等2件商标注册申请
证券之星 · 09-15
宣泰医药新提交“宣佳泰”、“宣家泰”等2件商标注册申请
每周股票复盘:宣泰医药(688247)变更签字注册会计师
证券之星 · 09-13
每周股票复盘:宣泰医药(688247)变更签字注册会计师
宣泰医药(688247)披露变更签字注册会计师公告,9月10日股价下跌3.99%
证券之星 · 09-10
宣泰医药(688247)披露变更签字注册会计师公告,9月10日股价下跌3.99%
暂无数据
公司概况
公司名称:
上海宣泰医药科技股份有限公司
所属行业:
医药制造业
上市日期:
2022-08-25
主营业务:
上海宣泰医药科技股份有限公司的主营业务是高端仿制药研发与产业化及创新药CRO/CMO一体化服务。公司的主要产品是泊沙康唑肠溶片、马昔腾坦片、美沙拉秦肠溶缓释片、西格列汀二甲双胍缓释片、格列净二甲双胍缓释片、奥拉帕利片、依西美坦片等。
发行价格:
9.37
{"stockData":{"symbol":"688247","market":"SH","secType":"STK","nameCN":"宣泰医药","latestPrice":7.42,"timestamp":1794985200000,"preClose":7.53,"halted":0,"volume":4006799,"delay":0,"changeRate":-0.0146,"floatShares":453000000,"shares":453000000,"eps":0.04,"marketStatus":"已收盘","change":-0.11,"latestTime":"11-18 15:00:00","open":7.56,"high":7.65,"low":7.33,"amount":29848100,"amplitude":0.0425,"askPrice":7.44,"askSize":28,"bidPrice":7.42,"bidSize":30,"shortable":0,"etf":0,"ttmEps":0.04,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1795051800000},"marketStatusCode":5,"adr":0,"adjPreClose":7.53,"symbolType":"stock_kcb","openAndCloseTimeList":[[1794965400000,1794972600000],[1794978000000,1794985200000]],"highLimit":8.28,"lowLimit":6.78,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":453340000,"isCdr":false,"pbRate":2.55,"roa":"--","peRate":185.5,"roe":"2.61%","epsLYR":0.11,"committee":-0.223881,"marketValue":3364000000,"turnoverRate":0.0088,"status":1,"afterMarket":{"amount":0,"volume":0,"close":7.42,"buyVolume":13600,"sellVolume":0,"time":1794987237746,"indexStatus":"已收盘 11-18 15:30:00","preClose":7.53},"floatMarketCap":3364000000},"requestUrl":"/m/hq/s/688247/tweets","defaultTab":"tweets","newsList":[{"id":"2684933437","title":"股市必读:宣泰医药(688247)11月17日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2684933437","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684933437?lang=zh_cn&edition=full","pubTime":"2026-11-18 03:26","pubTimestamp":1794943607,"startTime":"0","endTime":"0","summary":"截至2026年11月17日收盘,宣泰医药报收于7.53元,下跌2.84%,换手率1.11%,成交量5.02万手,成交额3829.1万元。董秘最新回复投资者: 您好,三季报期末货币资金约 8378 万元,较去年年末 4.07 亿元大幅下降。2026年前三季度,公司购建长期资产支付的现金1,696.49万元,同比有所下降。当日关注点交易信息汇总:11月17日主力资金净流出232.29万元,占总成交额6.07%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111800002986.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688247"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684341602","title":"宣泰医药:11月12日召开业绩说明会,投资者参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2684341602","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684341602?lang=zh_cn&edition=full","pubTime":"2026-11-17 19:17","pubTimestamp":1794914237,"startTime":"0","endTime":"0","summary":"证券之星消息,2026年11月13日宣泰医药发布公告称公司于2026年11月12日召开业绩说明会。宣泰医药2026年三季报显示,前三季度公司主营收入2.83亿元,同比下降14.75%;归母净利润3408.05万元,同比下降46.3%;扣非净利润2474.35万元,同比下降54.08%;其中2026年第三季度,公司单季度主营收入9141.93","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111700036307.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688247","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683207657","title":"股市必读:宣泰医药新发布《自愿披露关于泊沙康唑肠溶片获得哥伦比亚INVIMA批准文号的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2683207657","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683207657?lang=zh_cn&edition=full","pubTime":"2026-11-16 03:37","pubTimestamp":1794771428,"startTime":"0","endTime":"0","summary":"公司公告汇总自愿披露关于泊沙康唑肠溶片获得哥伦比亚INVIMA批准文号的公告上海宣泰医药科技股份有限公司收到哥伦比亚国家药品和食品监督管理局通知,公司产品泊沙康唑肠溶片的仿制药申请获得批准,具备在哥伦比亚市场销售的资格。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111600001168.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688247"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683497805","title":"宣泰医药(688247)11月12日主力资金净买入1533.01万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2683497805","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683497805?lang=zh_cn&edition=full","pubTime":"2026-11-13 08:16","pubTimestamp":1794528963,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年11月12日收盘,宣泰医药报收于8.22元,上涨1.86%,换手率2.67%,成交量12.08万手,成交额1.02亿元。近5日资金流向一览见下表:宣泰医药融资融券信息显示,融资方面,当日融资买入1283.2万元,融资偿还977.82万元,融资净买入305.38万元。宣泰医药主营业务:从事高技术壁垒的仿制药的研发、生产、销售,以及制剂CRO/CMO服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111300008996.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688247"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682566911","title":"宣泰医药(688247.SH):泊沙康唑肠溶片获得哥伦比亚INVIMA批准文号","url":"https://stock-news.laohu8.com/highlight/detail?id=2682566911","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682566911?lang=zh_cn&edition=full","pubTime":"2026-11-12 17:26","pubTimestamp":1794475617,"startTime":"0","endTime":"0","summary":"智通财经APP讯,宣泰医药(688247.SH)发布公告,近日,公司收到哥伦比亚国家药品和食品监督管理局(简称“哥伦比亚INVIMA”)的通知,公司产品泊沙康唑肠溶片的仿制药申请获得正式批准。泊沙康唑肠溶片主要用以治疗侵袭性曲霉菌或念珠菌感染,泊沙康唑是由伊曲康唑衍生出的第二代三唑类抗真菌药,通过抑制麦角固醇合成来发挥作用来治疗侵袭性曲霉菌或念珠菌感染,是目前临床常用的抗侵袭性真菌感染药品之一。泊沙康唑安全性强,无明显肝肾毒性,耐受性好,可用于需长期治疗的患者,尤其在预防免疫功能缺陷患者的深部真菌感染方面优于氟康唑或伊曲康唑等同类药物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1522321.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"宣泰医药(688247.SH):泊沙康唑肠溶片获得哥伦比亚INVIMA批准文号","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688247","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679553182","title":"股市必读:宣泰医药三季报 - 第三季度单季净利润同比下降75.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679553182","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679553182?lang=zh_cn&edition=full","pubTime":"2026-10-30 08:04","pubTimestamp":1793318682,"startTime":"0","endTime":"0","summary":"业绩披露要点:2026年第三季度单季度归母净利润437.88万元,同比下降75.51%。业绩披露要点财务报告宣泰医药2026年三季报显示,前三季度公司主营收入2.83亿元,同比下降14.75%;归母净利润3408.05万元,同比下降46.3%;扣非净利润2474.35万元,同比下降54.08%;其中2026年第三季度,公司单季度主营收入9141.93万元,同比下降18.27%;单季度归母净利润437.88万元,同比下降75.51%;单季度扣非净利润436.6万元,同比下降69.59%;负债率11.59%,投资收益1410.57万元,财务费用302.63万元,毛利率40.77%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000014650.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688247"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679419763","title":"股市必读:宣泰医药(688247)股东户数1.05万户,较上期增加36.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679419763","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679419763?lang=zh_cn&edition=full","pubTime":"2026-10-29 04:10","pubTimestamp":1793218233,"startTime":"0","endTime":"0","summary":"截至2026年10月28日收盘,宣泰医药报收于8.4元,上涨3.7%,换手率1.18%,成交量5.33万手,成交额4434.08万元。当日关注点交易信息汇总:10月28日主力资金净流出88.98万元,占总成交额2.01%。股本股东变化:截至2026年9月30日,宣泰医药股东户数为1.05万户,较6月30日增长36.59%。股本股东变化股东户数变动截至2026年9月30日公司股东户数为1.05万户,较6月30日增加2815.0户,增幅为36.59%;户均持股数量由上期的5.89万股减少至4.31万股,户均持股市值为43.53万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900004933.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688247"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678918334","title":"宣泰医药(688247.SH)发布前三季度业绩,归母净利润3408万元,同比下降46.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678918334","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678918334?lang=zh_cn&edition=full","pubTime":"2026-10-28 22:30","pubTimestamp":1793197833,"startTime":"0","endTime":"0","summary":"智通财经APP讯,宣泰医药(688247.SH)披露2026年第三季度报告,前三季度公司实现营业收入2.83亿元,同比下降14.75%;归母净利润3408万元,同比下降46.30%;扣非净利润2474万元,同比下降54.08%;基本每股收益0.08元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1514624.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688247"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678480218","title":"宣泰医药(688247)10月27日主力资金净卖出59.08万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2678480218","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678480218?lang=zh_cn&edition=full","pubTime":"2026-10-28 08:48","pubTimestamp":1793148533,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月27日收盘,宣泰医药报收于8.1元,下跌5.59%,换手率0.98%,成交量4.46万手,成交额3703.49万元。近5日资金流向一览见下表:宣泰医药融资融券信息显示,融资方面,当日融资买入461.44万元,融资偿还354.59万元,融资净买入106.85万元。宣泰医药主营业务:从事高技术壁垒的仿制药的研发、生产、销售,以及制剂CRO/CMO服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800014314.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688247","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677615544","title":"股市必读:宣泰医药新发布《关于股东部分股份解除质押的公告-1015_final》","url":"https://stock-news.laohu8.com/highlight/detail?id=2677615544","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677615544?lang=zh_cn&edition=full","pubTime":"2026-10-21 03:09","pubTimestamp":1792523350,"startTime":"0","endTime":"0","summary":"公司公告汇总:股东栖和创业解除质押10,000,000股,占其持股总数的50.00%,占公司总股本的2.21%。公司公告汇总关于股东部分股份解除质押的公告-1015_final截至公告披露日,股东栖和创业持有公司股份20,000,000股,占公司总股本的4.41%;本次解除质押10,000,000股,占其持股总数的50.00%,占公司总股本的2.21%;解除质押后,其累计质押股份为10,000,000股,占其持股总数的50.00%,占公司总股本的2.21%;相关解除质押登记手续已于2026年10月16日办理完成。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102100002013.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688247","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676504973","title":"宣泰医药(688247)披露2026年半年度权益分派实施公告,10月19日股价下跌2.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2676504973","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676504973?lang=zh_cn&edition=full","pubTime":"2026-10-19 17:30","pubTimestamp":1792402259,"startTime":"0","endTime":"0","summary":"截至2026年10月19日收盘,宣泰医药报收于8.6元,较前一交易日下跌2.6%,最新总市值为38.99亿元。该股当日开盘8.77元,最高9.02元,最低8.34元,成交额达6121.22万元,换手率为1.57%。近日,公司发布《2026年半年度权益分派实施公告》。股权登记日为2026年10月22日,除权(息)日和现金红利发放日均为2026年10月23日。差异化分红方案经2025年年度股东会授权,董事会审议通过。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900022509.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688247"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676780775","title":"股市必读:宣泰医药新发布《关于股东无偿捐赠部分公司股份完成过户的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2676780775","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676780775?lang=zh_cn&edition=full","pubTime":"2026-10-19 02:24","pubTimestamp":1792347851,"startTime":"0","endTime":"0","summary":"公司公告汇总关于股东无偿捐赠部分公司股份完成过户的公告上海宣泰医药科技股份有限公司股东Finer Pharma Inc.将其持有的200,000股公司股份捐赠给辽宁省沈阳药科大学教育基金会,用于支持沈阳药科大学的教育发展建设。公司因实施股份回购导致回购股份不参与利润分配,故本次分红构成差异化分红。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900000728.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688247","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675852304","title":"宣泰医药:Finer捐赠20万股完成过户","url":"https://stock-news.laohu8.com/highlight/detail?id=2675852304","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675852304?lang=zh_cn&edition=full","pubTime":"2026-10-15 15:52","pubTimestamp":1792050720,"startTime":"0","endTime":"0","summary":"10月15日,宣泰医药(688247.SH)公告,公司此前披露股东Finer Pharma Inc.拟将其持有的20万股公司股份捐赠给辽宁省沈阳药科大学教育基金会;近日双方已通过非交易过户完成20万股公司股份过户 ...","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261015/c680727439.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261015/c680727439.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["688247","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674889125","title":"宣泰医药(688247)10月8日主力资金净卖出498.32万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674889125","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674889125?lang=zh_cn&edition=full","pubTime":"2026-10-09 08:36","pubTimestamp":1791506164,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月8日收盘,宣泰医药报收于9.62元,下跌4.66%,换手率1.84%,成交量8.33万手,成交额8098.26万元。近5日资金流向一览见下表:宣泰医药融资融券信息显示,融资方面,当日融资买入764.39万元,融资偿还794.84万元,融资净偿还30.45万元。宣泰医药主营业务:从事高技术壁垒的仿制药的研发、生产、销售,以及制剂CRO/CMO服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900006313.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688247"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671266285","title":"宣泰医药(688247)9月28日主力资金净卖出200.76万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671266285","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671266285?lang=zh_cn&edition=full","pubTime":"2026-09-29 08:25","pubTimestamp":1790641525,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年9月28日收盘,宣泰医药报收于9.95元,上涨0.71%,换手率1.73%,成交量7.86万手,成交额7873.37万元。近5日资金流向一览见下表:宣泰医药融资融券信息显示,融资方面,当日融资买入590.91万元,融资偿还594.38万元,融资净偿还3.47万元。宣泰医药主营业务:从事高技术壁垒的仿制药的研发、生产、销售,以及制剂CRO/CMO服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900007153.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688247"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669432002","title":"宣泰医药(688247)9月23日主力资金净买入699.18万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2669432002","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669432002?lang=zh_cn&edition=full","pubTime":"2026-09-24 08:22","pubTimestamp":1790209363,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年9月23日收盘,宣泰医药报收于10.25元,上涨2.4%,换手率1.97%,成交量8.92万手,成交额9122.25万元。近5日资金流向一览见下表:宣泰医药融资融券信息显示,融资方面,当日融资买入917.68万元,融资偿还625.86万元,融资净买入291.81万元。宣泰医药主营业务:从事高技术壁垒的仿制药的研发、生产、销售,以及制剂CRO/CMO服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400007798.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688247"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667607712","title":"宣泰医药:9月15日召开业绩说明会,投资者参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2667607712","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667607712?lang=zh_cn&edition=full","pubTime":"2026-09-16 19:01","pubTimestamp":1789556477,"startTime":"0","endTime":"0","summary":"证券之星消息,2026年9月16日宣泰医药发布公告称公司于2026年9月15日召开业绩说明会。)获得日本厚生劳动省批准上市,并顺利承接其商业化阶段CMO生产服务。截至目前,公司已累计助力7款创新药获批上市并落地商业化生产,充分验证了一站式CDMO平台在跨区域创新药项目中的交付能力,行业口碑与市场影响力持续提升。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091600031713.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688247","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667321691","title":"宣泰医药新提交“宣佳泰”、“宣家泰”等2件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2667321691","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667321691?lang=zh_cn&edition=full","pubTime":"2026-09-15 07:22","pubTimestamp":1789428140,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示,近日上海宣泰医药科技股份有限公司新提交“宣佳泰”、“宣家泰”等2件商标注册申请。商标申请详情如下:今年以来上海宣泰医药科技股份有限公司新申请注册商标5件,截止目前公司共持有注册商标166件,另有23件商标尚在注册申请中。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091500004877.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688247","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667072085","title":"每周股票复盘:宣泰医药(688247)变更签字注册会计师","url":"https://stock-news.laohu8.com/highlight/detail?id=2667072085","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667072085?lang=zh_cn&edition=full","pubTime":"2026-09-13 02:38","pubTimestamp":1789238292,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘,宣泰医药报收于8.56元,较上周的9.11元下跌6.04%。本周,宣泰医药9月8日盘中最高价报9.42元。本周关注点公司公告汇总:宣泰医药变更2026年度签字注册会计师,由张君如接替缪雪。公司公告汇总上海宣泰医药科技股份有限公司于2026年9月11日发布公告,因原签字注册会计师缪雪工作调整,上会会计师事务所指派张君如接替其职务,作为公司2026年度财务报表和内部控制审计的签字注册会计师。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091300000714.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688247"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666910685","title":"宣泰医药(688247)披露变更签字注册会计师公告,9月10日股价下跌3.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666910685","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666910685?lang=zh_cn&edition=full","pubTime":"2026-09-10 22:35","pubTimestamp":1789050915,"startTime":"0","endTime":"0","summary":"截至2026年9月10日收盘,宣泰医药报收于8.9元,较前一交易日下跌3.99%,最新总市值为40.35亿元。近日,上海宣泰医药科技股份有限公司发布公告,因原签字注册会计师缪雪工作调整,上会会计师事务所指派张君如接替其职务,作为公司2026年度财务报表和内部控制审计的签字注册会计师。变更后,签字注册会计师为时英浩和张君如。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000042355.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688247"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1795027453001,"stockEarnings":[{"period":"1week","weight":-0.0805},{"period":"1month","weight":-0.1357},{"period":"3month","weight":-0.272},{"period":"6month","weight":-0.1646},{"period":"1year","weight":-0.3209},{"period":"ytd","weight":-0.2327}],"compareEarnings":[{"period":"1week","weight":-0.0252},{"period":"1month","weight":-0.0384},{"period":"3month","weight":-0.0809},{"period":"6month","weight":-0.1277},{"period":"1year","weight":-0.0893},{"period":"ytd","weight":-0.096}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海宣泰医药科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"10508人(较上一季度增加36.59%)","perCapita":"43142股","listingDate":"2022-08-25","address":"上海市浦东新区中国(上海)自由贸易试验区蔡伦路780号7层709室","registeredCapital":"45334万元","survey":" 上海宣泰医药科技股份有限公司的主营业务是高端仿制药研发与产业化及创新药CRO/CMO一体化服务。公司的主要产品是泊沙康唑肠溶片、马昔腾坦片、美沙拉秦肠溶缓释片、西格列汀二甲双胍缓释片、格列净二甲双胍缓释片、奥拉帕利片、依西美坦片等。","listedPrice":9.37},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.54.0","shortVersion":"4.54.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"宣泰医药(688247)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供宣泰医药(688247)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"宣泰医药,688247,宣泰医药股票,宣泰医药股票老虎,宣泰医药股票老虎国际,宣泰医药行情,宣泰医药股票行情,宣泰医药股价,宣泰医药股市,宣泰医药股票价格,宣泰医药股票交易,宣泰医药股票购买,宣泰医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"宣泰医药(688247)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供宣泰医药(688247)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}